vs
Side-by-side financial comparison of Invesco Mortgage Capital Inc. (IVR) and TriSalus Life Sciences, Inc. (TLSI). Click either name above to swap in a different company.
Invesco Mortgage Capital Inc. is the larger business by last-quarter revenue ($21.3M vs $13.2M, roughly 1.6× TriSalus Life Sciences, Inc.). Invesco Mortgage Capital Inc. runs the higher net margin — 242.2% vs -73.9%, a 316.1% gap on every dollar of revenue. On growth, TriSalus Life Sciences, Inc. posted the faster year-over-year revenue change (59.8% vs 55.4%). Over the past eight quarters, Invesco Mortgage Capital Inc.'s revenue compounded faster (74.2% CAGR vs 43.0%).
Invesco Ltd. is an American independent investment management company headquartered in Atlanta, Georgia, with branch offices in 20 countries. Its common stock is a constituent of the S&P 500 and trades on the New York Stock Exchange. Invesco operates under the Invesco, Invesco Perpetual, and Powershares brand names.
TriSalus Life Sciences, Inc. is a clinical-stage biotechnology company focused on advancing immuno-oncology and interventional oncology solutions. It develops proprietary targeted drug delivery technologies designed to improve treatment efficacy for patients with liver, pancreatic and other hard-to-treat solid tumors, primarily operating in North American markets via partnerships with clinical care and research institutions.
IVR vs TLSI — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $21.3M | $13.2M |
| Net Profit | $51.5M | $-9.8M |
| Gross Margin | — | 86.7% |
| Operating Margin | — | -24.8% |
| Net Margin | 242.2% | -73.9% |
| Revenue YoY | 55.4% | 59.8% |
| Net Profit YoY | 1368.7% | 3.5% |
| EPS (diluted) | $0.72 | $-0.22 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $21.3M | $13.2M | ||
| Q3 25 | $17.6M | $11.6M | ||
| Q2 25 | $17.7M | $11.2M | ||
| Q1 25 | $18.8M | $9.2M | ||
| Q4 24 | $13.7M | $8.3M | ||
| Q3 24 | $7.5M | $7.3M | ||
| Q2 24 | $8.6M | $7.4M | ||
| Q1 24 | $7.0M | $6.5M |
| Q4 25 | $51.5M | $-9.8M | ||
| Q3 25 | $53.5M | $-10.8M | ||
| Q2 25 | $-23.3M | $-8.3M | ||
| Q1 25 | $19.6M | $-10.4M | ||
| Q4 24 | $3.5M | $-10.1M | ||
| Q3 24 | $40.7M | $-2.4M | ||
| Q2 24 | $-13.5M | $-4.3M | ||
| Q1 24 | $29.1M | $-13.2M |
| Q4 25 | — | 86.7% | ||
| Q3 25 | — | 83.5% | ||
| Q2 25 | — | 83.9% | ||
| Q1 25 | — | 83.7% | ||
| Q4 24 | — | 85.3% | ||
| Q3 24 | — | 86.3% | ||
| Q2 24 | — | 87.6% | ||
| Q1 24 | — | 85.0% |
| Q4 25 | — | -24.8% | ||
| Q3 25 | — | -77.9% | ||
| Q2 25 | — | -65.4% | ||
| Q1 25 | — | -79.9% | ||
| Q4 24 | — | -91.8% | ||
| Q3 24 | — | -118.9% | ||
| Q2 24 | — | -111.0% | ||
| Q1 24 | — | -180.8% |
| Q4 25 | 242.2% | -73.9% | ||
| Q3 25 | 303.6% | -93.5% | ||
| Q2 25 | -131.6% | -73.9% | ||
| Q1 25 | 104.4% | -113.2% | ||
| Q4 24 | 25.6% | -122.4% | ||
| Q3 24 | 542.2% | -32.6% | ||
| Q2 24 | -155.9% | -58.8% | ||
| Q1 24 | 415.9% | -204.5% |
| Q4 25 | $0.72 | $-0.22 | ||
| Q3 25 | $0.74 | $-0.96 | ||
| Q2 25 | $-0.40 | $-0.27 | ||
| Q1 25 | $0.26 | $-0.39 | ||
| Q4 24 | $-0.09 | $-0.38 | ||
| Q3 24 | $0.63 | $-0.12 | ||
| Q2 24 | $-0.38 | $-0.21 | ||
| Q1 24 | $0.49 | $-0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $56.0M | $20.4M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $797.5M | $-33.9M |
| Total Assets | $6.5B | $35.3M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $56.0M | $20.4M | ||
| Q3 25 | $58.5M | $22.7M | ||
| Q2 25 | $59.4M | $26.5M | ||
| Q1 25 | $42.9M | $13.0M | ||
| Q4 24 | $73.4M | $8.5M | ||
| Q3 24 | $48.3M | $11.3M | ||
| Q2 24 | $58.8M | $16.5M | ||
| Q1 24 | $59.9M | $4.0M |
| Q4 25 | $797.5M | $-33.9M | ||
| Q3 25 | $769.6M | $-26.7M | ||
| Q2 25 | $709.4M | $-19.4M | ||
| Q1 25 | $759.2M | $-34.4M | ||
| Q4 24 | $730.7M | $-25.9M | ||
| Q3 24 | $857.0M | $-20.4M | ||
| Q2 24 | $759.2M | $-25.3M | ||
| Q1 24 | $785.6M | $-36.0M |
| Q4 25 | $6.5B | $35.3M | ||
| Q3 25 | $6.0B | $36.5M | ||
| Q2 25 | $5.4B | $41.3M | ||
| Q1 25 | $6.2B | $28.6M | ||
| Q4 24 | $5.7B | $24.0M | ||
| Q3 24 | $6.1B | $27.5M | ||
| Q2 24 | $5.1B | $32.4M | ||
| Q1 24 | $5.2B | $17.9M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $157.1M | $-2.5M |
| Free Cash FlowOCF − Capex | — | $-2.5M |
| FCF MarginFCF / Revenue | — | -19.1% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | 3.05× | — |
| TTM Free Cash FlowTrailing 4 quarters | — | $-19.1M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $157.1M | $-2.5M | ||
| Q3 25 | $37.3M | $-3.7M | ||
| Q2 25 | $40.6M | $-7.3M | ||
| Q1 25 | $19.3M | $-4.5M | ||
| Q4 24 | $183.2M | $-5.7M | ||
| Q3 24 | $30.8M | $-10.8M | ||
| Q2 24 | $33.0M | $-13.4M | ||
| Q1 24 | $57.5M | $-10.9M |
| Q4 25 | — | $-2.5M | ||
| Q3 25 | — | $-3.9M | ||
| Q2 25 | — | $-7.4M | ||
| Q1 25 | — | $-5.3M | ||
| Q4 24 | — | $-5.8M | ||
| Q3 24 | — | $-11.0M | ||
| Q2 24 | — | $-13.5M | ||
| Q1 24 | — | $-10.9M |
| Q4 25 | — | -19.1% | ||
| Q3 25 | — | -33.9% | ||
| Q2 25 | — | -66.1% | ||
| Q1 25 | — | -57.3% | ||
| Q4 24 | — | -69.7% | ||
| Q3 24 | — | -149.9% | ||
| Q2 24 | — | -183.1% | ||
| Q1 24 | — | -169.3% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 1.9% | ||
| Q2 25 | — | 0.8% | ||
| Q1 25 | — | 8.2% | ||
| Q4 24 | — | 0.6% | ||
| Q3 24 | — | 2.3% | ||
| Q2 24 | — | 0.8% | ||
| Q1 24 | — | 1.0% |
| Q4 25 | 3.05× | — | ||
| Q3 25 | 0.70× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.98× | — | ||
| Q4 24 | 52.24× | — | ||
| Q3 24 | 0.76× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 1.97× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
